NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Royalty Pharma plc Class A Ordinary Shares Share Price Chart

O H L

Royalty Pharma plc Class A Ordinary Shares Performance Overview

Days Range
$58.38Low
$58.91High

Markets Today

Previous Close$58.93
Open$58.63
Volume136,607
Day's Range$58.38 - $58.91
52W Range$34.63 - $64.38
Market Cap$26.04 B

Historical Performance

1M Returns-1.27
3M Returns+11.27
6M Returns+28.70
1Y Returns+64.93
5Y Returns+53.06
10Y Returns+2719.62

Royalty Pharma plc Class A Ordinary Shares Fundamentals

Market Cap$26.04 B
Dividend yield1.61
PE Ratio31.20
PEG RatioN/A
Revenue$2.38 B
ROE TTM0.11
EPS TTM$1.87
Quarterly Earnings Growth YOYN/A
PB Ratio4.92
EBITDA$1.56 B
Profit Margin32.42
Market Cap$26.04 B
Dividend yield1.61
PE Ratio31.20
PEG RatioN/A
Revenue$2.38 B
ROE TTM0.11
EPS TTM$1.87
Quarterly Earnings Growth YOYN/A
PB Ratio4.92
EBITDA$1.56 B
Profit Margin32.42

Royalty Pharma plc Class A Ordinary Shares Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$568.25 M$578.66 M$609.29 M$621.99 M$630.58 M$674.14 M
Gross Profit +$568.25 M$578.66 M$609.29 M$621.99 M$630.58 M$674.14 M
Operating Income $534.18 M$209.80 M$427.16 M$388.38 M$563.04 M$133.12 M
EBITDA $407.04 M$209.80 M$439.29 M$707.33 M$435.00 M$133.12 M
Interest Expense -$65.26 M-$68.67 M-$79.56 M-$94.17 M-$93.72 M-$93.62 M
Depreciation -$127.14 M$0$12.13 M$318.94 M-$128.04 M$0
Income Before Tax $434.43 M$92.64 M$444.21 M$355.91 M$468.26 M$81.49 M
Income Tax Expense $0$0$0$0$0$0
Net Income +$434.43 M$92.64 M$444.21 M$355.91 M$468.26 M$81.49 M
Net Profit Margin 76.45%16.01%72.91%57.22%74.26%12.09%

Royalty Pharma plc Class A Ordinary Shares Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $106.00 K$107.00 K$107.00 K$106.00 K$108.00 K$108.00 K
Reserve & Surplus $2.48 B$2.22 B$2.30 B$2.36 B$2.51 B$2.46 B
Non-Current Liabilities $6.64 B$7.61 B$9.20 B$9.27 B$9.34 B$9.40 B
Current Liabilities $1.18 B$1.21 B$530.80 M$636.21 M$535.68 M$630.93 M
Total Liabilities $7.82 B$8.82 B$9.73 B$9.91 B$9.88 B$10.03 B
Fixed Assets $0$0$0$0$0$0
Current Assets $1.84 B$1.52 B$1.85 B$1.53 B$1.43 B$1.76 B
Total Assets $17.61 B$18.32 B$19.35 B$19.62 B$19.82 B$19.82 B

Royalty Pharma plc Class A Ordinary Shares Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income $0$0$0$0$0$0
Operating Cash Flow $596.08 M$363.98 M$702.62 M$827.15 M$718.23 M$728.46 M
Investing Cash Flow $503.92 M-$311.98 M-$958.31 M-$847.80 M-$477.87 M-$229.72 M
Financing Cash Flow -$941.30 M-$507.81 M$562.74 M-$299.60 M-$272.67 M-$273.15 M
Change in Cash $158.69 M-$455.81 M$307.04 M-$320.25 M-$32.30 M$225.59 M

Royalty Pharma plc Class A Ordinary Shares Return Calculator

The Royalty Pharma plc Class A Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$15,166
Invested Amount$10,000
Est. Returns$5,166
Invest in USA Stock Today

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

FAQs

Royalty Pharma plc Class A Ordinary Shares (RPRX) share price as of September 18, 2026 is $58.39. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Royalty Pharma plc Class A Ordinary Shares (RPRX) Share by opening an international trading account with Angel One.
Purchasing Royalty Pharma plc Class A Ordinary Shares (RPRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Royalty Pharma plc Class A Ordinary Shares (RPRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Royalty Pharma plc Class A Ordinary Shares (RPRX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Royalty Pharma plc Class A Ordinary Shares on September 18, 2026, is $26.04 B.
Royalty Pharma plc Class A Ordinary Shares operates in the Financial sector, specifically in the Financial industry.
In order to invest in Royalty Pharma plc Class A Ordinary Shares (RPRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91